×
 
 Back to press room

Announcements

SGInnovate Welcomes Three New Learning and Talent Partners

Aug 18, 2026

SGInnovate welcomes three new learning and talent partners to its growing community: 2Strands Biosciences, CyberKnights Pte Ltd and Monomer Bio

logos4

Together with our robust network of ecosystem partners across industry, academia, and government, these new collaborations enhance Singapore’s ability to nurture deep tech talent at scale, supporting national efforts in upskilling, reskilling, and connecting people to meaningful, high-impact roles. 

 

Debleena

"2Strands Biosciences is an innovative early-stage precision diagnostic company developing blood-based monitoring tests for cancer patients. 2Strands' innovative target enrichment strategy uses proprietary probes and biochemical steps to achieve exceptional performance."

- Dr Debleena Ray, Founder & CEO, 2Strands Biosciences 

Stephen

"CyberKnights exists to give founders and operators a security partner that moves at their speed — compliance-first foundations, backed by the AI-driven detection and response capabilities that are becoming essential as the attacks themselves start using AI. We work with SMEs and scaling deep-tech companies across Singapore and the wider region, helping them build security into how they operate rather than bolt it on after something goes wrong.

Our collaboration with SGInnovate's learning team lets us bring that thinking straight to SGInnovate's startup and technical community. Through joint Tech Talks, we've moved past generic cyber-awareness content into sessions built for people who already know the basics — covering AI-assisted attacks, zero-day exposure, and how MDR and AI-SOC capabilities are reshaping both sides of the fight. It has given us a direct line into the deep-tech founders SGInnovate has built its community around, and the chance to help them think about security before it becomes a crisis, not after."

- Dr. Stephen K. Hon, Head of Growth & Sales, CyberKnights Pte Ltd 

Yang Choo

"Monomer Bio is building the operating system for biotechnology research. Its goal is to transform lab research from a manual, time-intensive exercise into a methodical operation powered by hardware, automation, and data science."

- Yang Choo, CTO, Monomer Bio